Cite

HARVARD Citation

    Goto, K. et al. (2016). Bevacizumab for non‐small‐cell lung cancer: A nested case control study of risk factors for hemoptysis. Cancer science. 107 (12), pp. 1837-1842. [Online]. 
  
Back to record